A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.
Clinical trial NCT02856919 · COMPLETED
Trial details
- NCT number
- NCT02856919
- Sponsor
- Galderma Brasil Ltda.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2017-02-08
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.